Moderna Stock Jumps After $2.25B Patent Settlement Clears Legal Uncertainty
Moderna shares surged nearly 10% in premarket trading Wednesday after the company settled a long-running dispute over technology behind its COVID-19 vaccine. The agreement removes a major legal overhang, allowing the biotech
